{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T17:51:45Z","timestamp":1784310705828,"version":"3.55.0"},"reference-count":57,"publisher":"American Society of Hematology","issue":"21","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2015,11,19]]},"abstract":"<jats:title>Key Points<\/jats:title><jats:p>Factor V and protein S are required for sepsis mortality reduction and suppression of inflammatory gene expression by activated protein C. The R506Q mutation (Leiden mutation) abrogates the anti-inflammatory cofactor function of factor V for activated protein C.<\/jats:p>","DOI":"10.1182\/blood-2015-05-644401","type":"journal-article","created":{"date-parts":[[2015,9,5]],"date-time":"2015-09-05T02:49:12Z","timestamp":1441421352000},"page":"2415-2423","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":29,"title":["Coagulation factor V mediates inhibition of tissue factor signaling by activated protein C in mice"],"prefix":"10.1182","volume":"126","author":[{"given":"Hai Po H.","family":"Liang","sequence":"first","affiliation":[{"name":"Blood Research Institute, Blood Center of Wisconsin, Milwaukee, WI;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward J.","family":"Kerschen","sequence":"additional","affiliation":[{"name":"Blood Research Institute, Blood Center of Wisconsin, Milwaukee, WI;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sreemanti","family":"Basu","sequence":"additional","affiliation":[{"name":"Blood Research Institute, Blood Center of Wisconsin, Milwaukee, WI;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Hernandez","sequence":"additional","affiliation":[{"name":"Blood Research Institute, Blood Center of Wisconsin, Milwaukee, WI;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Zogg","sequence":"additional","affiliation":[{"name":"Blood Research Institute, Blood Center of Wisconsin, Milwaukee, WI;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuang","family":"Jia","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Medical College of Wisconsin, Children's Research Institute, Children's Hospital of Wisconsin, Milwaukee, WI;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin J.","family":"Hessner","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Medical College of Wisconsin, Children's Research Institute, Children's Hospital of Wisconsin, Milwaukee, WI;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raffaella","family":"Toso","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Pediatrics, The Children's Hospital of Philadelphia, Philadelphia, PA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alireza R.","family":"Rezaie","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and Molecular Biology, St Louis University School of Medicine, St Louis, MO;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 A.","family":"Fern\u00e1ndez","sequence":"additional","affiliation":[{"name":"Department of Molecular and Experimental Medicine, The Scripps Research Institute, La Jolla, CA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodney M.","family":"Camire","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Pediatrics, The Children's Hospital of Philadelphia, Philadelphia, PA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfram","family":"Ruf","sequence":"additional","affiliation":[{"name":"Department of Immunology and Microbial Science, The Scripps Research Institute, La Jolla, CA; and"},{"name":"Center for Thrombosis and Hemostasis, Mainz, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John H.","family":"Griffin","sequence":"additional","affiliation":[{"name":"Department of Molecular and Experimental Medicine, The Scripps Research Institute, La Jolla, CA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hartmut","family":"Weiler","sequence":"additional","affiliation":[{"name":"Blood Research Institute, Blood Center of Wisconsin, Milwaukee, WI;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"Suppl 1","key":"2019111902005876800_B1","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1055\/s-2006-939554","article-title":"Inflammation and the activated protein C anticoagulant pathway.","volume":"32","author":"Esmon","year":"2006","journal-title":"Semin Thromb Hemost"},{"key":"2019111902005876800_B2","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.2741\/1977","article-title":"Protein C anticoagulant activity in relation to anti-inflammatory and anti-apoptotic activities.","volume":"11","author":"Mosnier","year":"2006","journal-title":"Front Biosci"},{"issue":"7","key":"2019111902005876800_B3","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1161\/01.ATV.0000168421.13467.82","article-title":"Regulation of blood coagulation by the protein C anticoagulant pathway: novel insights into structure-function relationships and molecular recognition.","volume":"25","author":"Dahlb\u00e4ck","year":"2005","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"3","key":"2019111902005876800_B4","doi-asserted-by":"crossref","first-page":"185","DOI":"10.5482\/ha-1166","article-title":"Multiple receptor-mediated functions of activated protein C.","volume":"31","author":"Weiler","year":"2011","journal-title":"Hamostaseologie"},{"issue":"8","key":"2019111902005876800_B5","doi-asserted-by":"crossref","first-page":"3161","DOI":"10.1182\/blood-2006-09-003004","article-title":"The cytoprotective protein C pathway.","volume":"109","author":"Mosnier","year":"2007","journal-title":"Blood"},{"issue":"15","key":"2019111902005876800_B6","doi-asserted-by":"crossref","first-page":"3310","DOI":"10.1016\/j.febslet.2005.03.001","article-title":"The anticoagulant protein C pathway.","volume":"579","author":"Dahlb\u00e4ck","year":"2005","journal-title":"FEBS Lett"},{"issue":"9","key":"2019111902005876800_B7","doi-asserted-by":"crossref","first-page":"3167","DOI":"10.1172\/JCI42629","article-title":"Activated protein C targets CD8+ dendritic cells to reduce the mortality of endotoxemia in mice.","volume":"120","author":"Kerschen","year":"2010","journal-title":"J Clin Invest"},{"issue":"10","key":"2019111902005876800_B8","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.1084\/jem.20070404","article-title":"Endotoxemia and sepsis mortality reduction by non-anticoagulant activated protein C.","volume":"204","author":"Kerschen","year":"2007","journal-title":"J Exp Med"},{"issue":"6","key":"2019111902005876800_B9","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1172\/JCI40380","article-title":"The efficacy of activated protein C in murine endotoxemia is dependent on integrin CD11b.","volume":"120","author":"Cao","year":"2010","journal-title":"J Clin Invest"},{"issue":"23","key":"2019111902005876800_B10","doi-asserted-by":"crossref","first-page":"5970","DOI":"10.1182\/blood-2008-10-183327","article-title":"Hyperantithrombotic, noncytoprotective Glu149Ala-activated protein C mutant.","volume":"113","author":"Mosnier","year":"2009","journal-title":"Blood"},{"issue":"3","key":"2019111902005876800_B11","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1111\/j.1538-7836.2009.03711.x","article-title":"APC resistance: biological basis and acquired influences.","volume":"8","author":"Castoldi","year":"2010","journal-title":"J Thromb Haemost"},{"issue":"1","key":"2019111902005876800_B12","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1160\/TH11-06-0431","article-title":"The anticoagulant function of coagulation factor V.","volume":"107","author":"Cramer","year":"2012","journal-title":"Thromb Haemost"},{"issue":"9","key":"2019111902005876800_B13","doi-asserted-by":"crossref","first-page":"3085","DOI":"10.1182\/blood-2003-06-1789","article-title":"Survival advantage associated with heterozygous factor V Leiden mutation in patients with severe sepsis and in mouse endotoxemia.","volume":"102","author":"Kerlin","year":"2003","journal-title":"Blood"},{"issue":"6","key":"2019111902005876800_B14","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1111\/jth.12876","article-title":"Survival advantage of heterozygous factor V Leiden carriers in murine sepsis.","volume":"13","author":"Kerschen","year":"2015","journal-title":"J Thromb Haemost"},{"issue":"13","key":"2019111902005876800_B15","doi-asserted-by":"crossref","first-page":"4222","DOI":"10.1182\/blood.V96.13.4222","article-title":"Spontaneous thrombosis in mice carrying the factor V Leiden mutation.","volume":"96","author":"Cui","year":"2000","journal-title":"Blood"},{"issue":"1","key":"2019111902005876800_B16","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/ng0595-119","article-title":"Targeted disruption of the mouse factor VIII gene produces a model of haemophilia A.","volume":"10","author":"Bi","year":"1995","journal-title":"Nat Genet"},{"issue":"6851","key":"2019111902005876800_B17","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/35092573","article-title":"Role of thrombin signalling in platelets in haemostasis and thrombosis.","volume":"413","author":"Sambrano","year":"2001","journal-title":"Nature"},{"issue":"17","key":"2019111902005876800_B18","doi-asserted-by":"crossref","first-page":"4078","DOI":"10.1182\/blood-2008-09-180968","article-title":"Recombinant human activated protein C inhibits integrin-mediated neutrophil migration.","volume":"113","author":"Elphick","year":"2009","journal-title":"Blood"},{"issue":"6","key":"2019111902005876800_B19","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1182\/blood-2004-01-0110","article-title":"Activated protein C variants with normal cytoprotective but reduced anticoagulant activity.","volume":"104","author":"Mosnier","year":"2004","journal-title":"Blood"},{"issue":"9","key":"2019111902005876800_B20","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1016\/j.bbagen.2008.05.004","article-title":"Functional properties and active-site topographies of factor X Gla- and prothrombin Gla-domain chimeras of activated protein C.","volume":"1780","author":"Qureshi","year":"2008","journal-title":"Biochim Biophys Acta"},{"issue":"12","key":"2019111902005876800_B21","doi-asserted-by":"crossref","first-page":"3405","DOI":"10.1182\/blood.V85.12.3405.bloodjournal85123405","article-title":"Activated protein C resistance: molecular mechanisms based on studies using purified Gln506-factor V.","volume":"85","author":"Heeb","year":"1995","journal-title":"Blood"},{"issue":"20","key":"2019111902005876800_B22","doi-asserted-by":"crossref","first-page":"15033","DOI":"10.1074\/jbc.M701315200","article-title":"Inhibitory sequences within the B-domain stabilize circulating factor V in an inactive state.","volume":"282","author":"Zhu","year":"2007","journal-title":"J Biol Chem"},{"issue":"7","key":"2019111902005876800_B23","doi-asserted-by":"crossref","first-page":"2932","DOI":"10.1172\/JCI46129","article-title":"P2X7 receptor signaling contributes to tissue factor-dependent thrombosis in mice.","volume":"121","author":"Furlan-Freguia","year":"2011","journal-title":"J Clin Invest"},{"issue":"20","key":"2019111902005876800_B24","doi-asserted-by":"crossref","first-page":"4762","DOI":"10.1182\/blood-2011-10-386185","article-title":"Inhibition of factor XI activation attenuates inflammation and coagulopathy while improving the survival of mouse polymicrobial sepsis.","volume":"119","author":"Tucker","year":"2012","journal-title":"Blood"},{"issue":"8","key":"2019111902005876800_B25","doi-asserted-by":"crossref","first-page":"6567","DOI":"10.1074\/jbc.M308574200","article-title":"Factor Va is inactivated by activated protein C in the absence of cleavage sites at Arg-306, Arg-506, and Arg-679.","volume":"279","author":"van der Neut Kolfschoten","year":"2004","journal-title":"J Biol Chem"},{"issue":"1","key":"2019111902005876800_B26","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0022-1759(98)00204-X","article-title":"An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow.","volume":"223","author":"Lutz","year":"1999","journal-title":"J Immunol Methods"},{"issue":"18","key":"2019111902005876800_B27","doi-asserted-by":"crossref","first-page":"2845","DOI":"10.1182\/blood-2014-11-610717","article-title":"EPCR-dependent PAR2 activation by the blood coagulation initiation complex regulates LPS-triggered interferon responses in mice.","volume":"125","author":"Liang","year":"2015","journal-title":"Blood"},{"issue":"8","key":"2019111902005876800_B28","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1161\/01.ATV.0000173419.31242.56","article-title":"Regulation of tissue factor--mediated initiation of the coagulation cascade by cell surface grp78.","volume":"25","author":"Bhattacharjee","year":"2005","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"12","key":"2019111902005876800_B29","doi-asserted-by":"crossref","first-page":"2738","DOI":"10.1111\/j.1538-7836.2005.01649.x","article-title":"Role of coagulation FVIII in septic peritonitis assessed in hemophilic mice.","volume":"3","author":"Schoenmakers","year":"2005","journal-title":"J Thromb Haemost"},{"issue":"2","key":"2019111902005876800_B30","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.thromres.2009.11.003","article-title":"Factor V Leiden and hemophilia.","volume":"125","author":"Franchini","year":"2010","journal-title":"Thromb Res"},{"issue":"8","key":"2019111902005876800_B31","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1111\/j.1538-7836.2004.00783.x","article-title":"Impaired hemostasis and protection against thrombosis in protease-activated receptor 4-deficient mice is due to lack of thrombin signaling in platelets.","volume":"2","author":"Hamilton","year":"2004","journal-title":"J Thromb Haemost"},{"issue":"11","key":"2019111902005876800_B32","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1038\/nm.2053","article-title":"Extracellular histones are major mediators of death in sepsis.","volume":"15","author":"Xu","year":"2009","journal-title":"Nat Med"},{"issue":"3","key":"2019111902005876800_B33","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1111\/j.1538-7836.2010.04177.x","article-title":"Activated protein C modulates inflammation, apoptosis and tissue factor procoagulant activity by regulating endoplasmic reticulum calcium depletion in blood monocytes.","volume":"9","author":"Toltl","year":"2011","journal-title":"J Thromb Haemost"},{"issue":"26","key":"2019111902005876800_B34","doi-asserted-by":"crossref","first-page":"19959","DOI":"10.1074\/jbc.M110.101030","article-title":"Engineering of substrate selectivity for tissue factor.factor VIIa complex signaling through protease-activated receptor 2.","volume":"285","author":"Larsen","year":"2010","journal-title":"J Biol Chem"},{"issue":"22","key":"2019111902005876800_B35","doi-asserted-by":"crossref","first-page":"23038","DOI":"10.1074\/jbc.M401376200","article-title":"Protease-activated receptor 2-dependent phosphorylation of the tissue factor cytoplasmic domain.","volume":"279","author":"Ahamed","year":"2004","journal-title":"J Biol Chem"},{"issue":"5574","key":"2019111902005876800_B36","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1126\/science.1071699","article-title":"Activation of endothelial cell protease activated receptor 1 by the protein C pathway.","volume":"296","author":"Riewald","year":"2002","journal-title":"Science"},{"issue":"7","key":"2019111902005876800_B37","doi-asserted-by":"crossref","first-page":"5756","DOI":"10.1074\/jbc.M110.201228","article-title":"The endothelial protein C receptor supports tissue factor ternary coagulation initiation complex signaling through protease-activated receptors.","volume":"286","author":"Disse","year":"2011","journal-title":"J Biol Chem"},{"issue":"12","key":"2019111902005876800_B38","doi-asserted-by":"crossref","first-page":"2516","DOI":"10.1111\/j.1538-7836.2011.04521.x","article-title":"Endothelial protein C receptor is required for tissue factor ternary complex signaling in the mouse.","volume":"9","author":"Disse","year":"2011","journal-title":"J Thromb Haemost"},{"issue":"3","key":"2019111902005876800_B39","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/j.jmb.2007.05.042","article-title":"Active and exo-site inhibition of human factor Xa: structure of des-Gla factor Xa inhibited by NAP5, a potent nematode anticoagulant protein from Ancylostoma caninum.","volume":"371","author":"Rios-Steiner","year":"2007","journal-title":"J Mol Biol"},{"issue":"12","key":"2019111902005876800_B40","doi-asserted-by":"crossref","first-page":"9251","DOI":"10.1074\/jbc.M610547200","article-title":"Engineering a disulfide bond to stabilize the calcium-binding loop of activated protein C eliminates its anticoagulant but not its protective signaling properties.","volume":"282","author":"Bae","year":"2007","journal-title":"J Biol Chem"},{"issue":"45","key":"2019111902005876800_B41","doi-asserted-by":"crossref","first-page":"30531","DOI":"10.1074\/jbc.M802338200","article-title":"Dissociation of activated protein C functions by elimination of protein S cofactor enhancement.","volume":"283","author":"Harmon","year":"2008","journal-title":"J Biol Chem"},{"issue":"35","key":"2019111902005876800_B42","doi-asserted-by":"crossref","first-page":"25493","DOI":"10.1074\/jbc.M702131200","article-title":"Identification of a specific exosite on activated protein C for interaction with protease-activated receptor 1.","volume":"282","author":"Yang","year":"2007","journal-title":"J Biol Chem"},{"issue":"1","key":"2019111902005876800_B43","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1002\/pro.5560060115","article-title":"Nonenzymatic anticoagulant activity of the mutant serine protease Ser360Ala-activated protein C mediated by factor Va.","volume":"6","author":"Gale","year":"1997","journal-title":"Protein Sci"},{"issue":"39","key":"2019111902005876800_B44","doi-asserted-by":"crossref","first-page":"28850","DOI":"10.1074\/jbc.M604966200","article-title":"Multifunctional specificity of the protein C\/activated protein C Gla domain.","volume":"281","author":"Preston","year":"2006","journal-title":"J Biol Chem"},{"issue":"1","key":"2019111902005876800_B45","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/j.1365-2567.2011.03511.x","article-title":"Toll-like receptor-mediated inhibition of Gas6 and ProS expression facilitates inflammatory cytokine production in mouse macrophages.","volume":"135","author":"Deng","year":"2012","journal-title":"Immunology"},{"issue":"26","key":"2019111902005876800_B46","doi-asserted-by":"crossref","first-page":"16140","DOI":"10.1074\/jbc.273.26.16140","article-title":"The C-terminal region of the factor V B-domain is crucial for the anticoagulant activity of factor V.","volume":"273","author":"Thorelli","year":"1998","journal-title":"J Biol Chem"},{"issue":"12","key":"2019111902005876800_B47","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1111\/j.1538-7836.2009.03622.x","article-title":"The molecular basis of factor V and VIII procofactor activation.","volume":"7","author":"Camire","year":"2009","journal-title":"J Thromb Haemost"},{"issue":"42","key":"2019111902005876800_B48","doi-asserted-by":"crossref","first-page":"7479","DOI":"10.2174\/1381612819666131230131454","article-title":"Phase 1 safety, tolerability and pharmacokinetics of 3K3A-APC in healthy adult volunteers.","volume":"19","author":"Lyden","year":"2013","journal-title":"Curr Pharm Des"},{"issue":"3","key":"2019111902005876800_B49","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1161\/CIRCULATIONAHA.113.003191","article-title":"Factor Xa activation of factor V is of paramount importance in initiating the coagulation system: lessons from a tick salivary protein.","volume":"128","author":"Schuijt","year":"2013","journal-title":"Circulation"},{"issue":"9","key":"2019111902005876800_B50","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1111\/j.1538-7836.2010.03919.x","article-title":"Zn\u00b2(+) -containing protein S inhibits extrinsic factor X-activating complex independently of tissue factor pathway inhibitor.","volume":"8","author":"Fernandes","year":"2010","journal-title":"J Thromb Haemost"},{"issue":"19","key":"2019111902005876800_B51","doi-asserted-by":"crossref","first-page":"2934","DOI":"10.1182\/blood-2013-11-512764","article-title":"Biology of tissue factor pathway inhibitor.","volume":"123","author":"Wood","year":"2014","journal-title":"Blood"},{"issue":"9","key":"2019111902005876800_B52","doi-asserted-by":"crossref","first-page":"3381","DOI":"10.1182\/blood-2003-06-2092","article-title":"Functional characterization of factor V-Ile359Thr: a novel mutation associated with thrombosis.","volume":"103","author":"Steen","year":"2004","journal-title":"Blood"},{"issue":"15","key":"2019111902005876800_B53","doi-asserted-by":"crossref","first-page":"2420","DOI":"10.1182\/blood-2013-10-530089","article-title":"Novel FV mutation (W1920R, FVNara) associated with serious deep vein thrombosis and more potent APC resistance relative to FVLeiden.","volume":"123","author":"Nogami","year":"2014","journal-title":"Blood"},{"issue":"4","key":"2019111902005876800_B54","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1074\/jbc.M308600200","article-title":"Unique in vivo modifications of coagulation factor V produce a physically and functionally distinct platelet-derived cofactor: characterization of purified platelet-derived factor V\/Va.","volume":"279","author":"Gould","year":"2004","journal-title":"J Biol Chem"},{"issue":"11","key":"2019111902005876800_B55","doi-asserted-by":"crossref","first-page":"4173","DOI":"10.1182\/blood-2003-10-3578","article-title":"Impaired APC cofactor activity of factor V plays a major role in the APC resistance associated with the factor V Leiden (R506Q) and R2 (H1299R) mutations.","volume":"103","author":"Castoldi","year":"2004","journal-title":"Blood"},{"issue":"28","key":"2019111902005876800_B56","doi-asserted-by":"crossref","first-page":"21130","DOI":"10.1016\/S0021-9258(19)36902-9","article-title":"Characterization of two forms of human factor Va with different cofactor activities.","volume":"268","author":"Rosing","year":"1993","journal-title":"J Biol Chem"},{"issue":"11","key":"2019111902005876800_B57","doi-asserted-by":"crossref","first-page":"3331","DOI":"10.1021\/bi9623284","article-title":"Human factor Va1 and factor Va2: properties in the procoagulant and anticoagulant pathways.","volume":"36","author":"Hoekema","year":"1997","journal-title":"Biochemistry"}],"updated-by":[{"DOI":"10.1182\/blood-2018-04-845131","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2018,5,31]],"date-time":"2018-05-31T00:00:00Z","timestamp":1527724800000}}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/126\/21\/2415\/1390122\/2415.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/126\/21\/2415\/1390122\/2415.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,21]],"date-time":"2022-05-21T12:32:32Z","timestamp":1653136352000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/126\/21\/2415\/34662\/Coagulation-factor-V-mediates-inhibition-of-tissue"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11,19]]},"references-count":57,"journal-issue":{"issue":"21","published-print":{"date-parts":[[2015,11,19]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2015-05-644401","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,11,19]]}}}